The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting is considered the premier event for professionals in gene and cell therapy.

Our PhD student Jenna participated at this year’s ASGCT Annual Meeting in Los Angeles.

The abstract titled “Enhancing the precision of designer site-specific recombinases: Methods for surveying sequence specificity and mitigating potential off-target effects” was presented during the first poster session on May 17th.

All abstracts are published in Molecular Therapy (DOI).